| |
 |
SYM |
Description |
|
|
BJCT |
Needle-free delivery system for the administration of therapeutic agents |
 |
|
|
|
|
|
|
|
Private |
Imaging products used to diagnose diabetic foot complications and peripheral arterial disease |
|
|
|
|
|
|
 |
|
Private |
Manufactures insulin supplies for people with diabetes. |
|
|
|
|
|
|
|
|
Private |
Products for patients with insulin-requiring diabetes. |
|
|
|
|
|
|
|
|
private |
Medical device company developing continuous, non-invasive glucose sensor for acute care and ambulatory diabetes market.
|
|
|
|
|
|
|
|
|
Private |
Developing a noninvasive screening device for diabetes |
|
|
|
|
|
|
|
|
Private |
Researches and develops a non-invasive medical device to measure blood glucose levels for diabetes management. |
|
|
|
|
|
|
|
|
Private |
Develops and manufactures blood glucose monitoring products for the diabetes market. |
|
|
|
|
|
|
|
|
Private |
Diabetes diagnostics. |
|
|
|
|
|
|
|
|
Private |
Developing treatments for insulin dependent diabetes. |
|
|
|
|
|
|
|
|
Private |
Sankyo's research is focused on treating cardiovascular conditions and metabolic disorders like diabetes, infection, and cancer. |
|
|
|
|
|
|
|
|
Private |
Diabetes risk assessment. |
|
|
|
|
|
|
|
|
Private |
Single-use diabetes monitoring products |
|
|
|
|
|
|
|
|
Private |
Diabetes monitoring and diagnostics. |
|
|
|
|
|
|
|
|
Private |
Developing multi-test handheld episodic glucose monitor system for diabetes. |
|
|
|
|
|
|
|
|
Private |
Treatment of human muscular degenerative diseases, as well as Type II diabetes and obesity. |
|
|
|
|
|
|
|
|
OPXA |
Cell therapies to treat autoimmune diseases such as MS, rheumatoid arthritis, and diabetes. |
|
|
|
|
|
|
|
|
HDIX |
Diabetes monitoring products. |
|
|
|
|
|
|
|
|
DXCM |
Technologies for the continuous monitoring of glucose in people with diabetes. |
|
|
|
|
|
|
|
|
PODD |
Treatment options for diabetes management through technology development. |
|
|
|
|
|
|
|
|
Private |
Peptide-based drugs to treat diabetes, heart failure, arrhythmias, and chemotherapy-induced diarrhea. |
|
|
|
|
|
|
|
|
Private |
Drugs for diabetes and obesity. |
|
|
|
|
|
|
|
|
Private |
Defining and validating drug compounds and target genes in obesity, diabetes, and similar fields. |
|
|
|
|
|
|
|
|
Private |
Drugs for obesity, hypercholesterolemia and type II diabetes. |
|
|
|
|
|
|
|
|
Private |
Testing equipment and services for people with diabetes. |
|
|
|
|
|
|
|
|
Private |
Pharmaceuticals within the fields of diabetes and metabolic diseases. |
|
|
|
|
|
|
|
|
Private |
Pharmaceutical products for the treatment in the areas of cardiovascular, CNS, diabetes, and antiinfectives. |
|
|
|
|
|
|
|
|
Private |
Therapies for metabolic disorders, such as obesity and diabetes. |
|
|
|
|
|
|
|
|
Private |
Drugs for the treatment of type 2 diabetes. |
|
|
|
|
|
|
|
|
Private |
Drug delivery systems for hypoparathyroidism, diabetes, oncology and neurodegeneration. |
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
OneMedPlace Member
